Clinical Trials for Zenith Epigenetics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Zenith Epigenetics

Clinical Trials (6)

NCT06922318
The COSMYC Trial (COmbined Suppression of MYC)
PHASE2Recruiting
50 participants
Started: Aug 19, 2025 · Completed: Aug 30, 2031
1 condition3 sponsors1 location
NCT05071937
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
PHASE2Recruiting
33 participants
Started: Apr 21, 2023 · Completed: Mar 1, 2033
3 conditions3 sponsors1 location
NCT05607108
A Study of ZEN003694 in People With Squamous Cell Lung Cancer
PHASE2Recruiting
25 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT04986423
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
PHASE2Recruiting
200 participants
Started: Sep 8, 2021 · Completed: Jun 30, 2026
1 condition3 sponsors31 locations
NCT04471974
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
PHASE2Active, not recruiting
61 participants
Started: Jan 26, 2021 · Completed: May 31, 2028
6 conditions4 sponsors3 locations
NCT04145375
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
PHASE1/PHASE2Enrolling by invitation
40 participants
Started: Nov 12, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations